The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp.
 
Manuel Rodrigues
Honoraria - Immunocore
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Research Funding - Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Mathilde Saint-Ghislain
Honoraria - oncostream; oncostream
 
Toulsie Ramtohul
No Relationships to Disclose
 
Leanne de Koning
No Relationships to Disclose
 
Clémentine Bouchez
No Relationships to Disclose
 
Elsa Lafite
No Relationships to Disclose
 
Zahra Castel Ajgal
No Relationships to Disclose
 
Gregoire Marret
No Relationships to Disclose
 
Raphaël Sanchez
No Relationships to Disclose
 
Pascale Mariani
No Relationships to Disclose
 
Sandra Nespoulous
No Relationships to Disclose
 
Véronique Gillon
No Relationships to Disclose
 
Vincent Servois
No Relationships to Disclose
 
Sophie Piperno-Neumann
Consulting or Advisory Role - Immunocore; Pierre Fabre
Research Funding - Foghorn Therapeutics (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Novartis; PharmaMar